The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas

Background: Although, standard treatment of Papillary Thyroid Carcinoma (PTC), involving surgery followed by radioactive iodine (RAI) therapy, is curative for most patients, 5-20% of patients develop RAI refractory disease. The repertoire of genomic events enabling RAI refractory disease in PTC need...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Kuraya, Khawla Sami, Siraj, Sarah, Masoodi, Tariq, Siraj, Abdul Khalid, Azam, Saud, Qadri, Zeeshan, Al-Dayel, Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090190/
http://dx.doi.org/10.1210/jendso/bvab048.1779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090190/
http://dx.doi.org/10.1210/jendso/bvab048.1779

Ejemplares similares